base metals investing Ardelyx Presents Analysis Supporting Long-Term Safety of XPHOZAH at NKF's Spring Clinical Meetings
base metals investing Ardelyx Reports First Quarter 2026 Financial Results and Provides Business Update
base metals investing Ardelyx Announces Abstract Accepted for Poster Presentation at the NKF's Spring Clinical Meetings
base metals investing Ardelyx Announces Abstract Exploring IBS-C Treatment Patterns Accepted for Poster Presentation at Digestive Disease Week 2026
base metals investing Ardelyx Announces Publication of a Review Article Demonstrating Rapid and Meaningful Symptom Relief with Tenapanor in IBS-C
base metals investing Ardelyx Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
base metals investing Ardelyx to Report Full Year and Fourth Quarter 2025 Financial Results on February 19, 2026
base metals investing First Patient Dosed in ACCEL: Phase 3 Chronic Idiopathic Constipation Study of IBSRELA
Alvopetro Announces Q3 2026 Dividend of US$0.12 Per Share and Supplementary Information on December 31, 2025 Prospective Resources
Skyharbour Partner Company Purecore Commences Data Compilation and Target Generation at The Yurchison Uranium Property
